Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2024

Description

Human immunodeficiency virus (HIV) diagnosis encompasses the process of determining whether an individual has contracted the human immunodeficiency virus, which leads to acquired immunodeficiency syndrome (AIDS). This diagnostic procedure involves testing for the presence of HIV antibodies, antigens, or viral genetic material in bodily fluids such as blood, saliva, or other relevant specimens.

The primary products utilized in HIV diagnosis include consumables, instruments, and software and services. Consumables refer to materials or supplies that are used up during diagnostic procedures, and they can be deployed in various formats including self-tests and lab-based assays. These products find application across diverse end users such as diagnostic laboratories, hospitals, and research institutions.

The HIV diagnosis market research report is one of a series of new reports from The Business Research Company that provides HIV diagnosis market statistics, including HIV diagnosis industry global market size, regional shares, competitors with a HIV diagnosis market share, detailed HIV diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the HIV diagnosis industry. This HIV diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The HIV diagnosis market size has grown rapidly in recent years. It will grow from $3.79 billion in 2023 to $4.2 billion in 2024 at a compound annual growth rate (CAGR) of 11%. The growth observed in the historical period can be attributed to several key factors, including the expansion of voluntary counseling and testing programs, the development of HIV antibody tests enabling wider screening, the emergence of the HIV/AIDS epidemic prompting heightened awareness and response efforts, and the implementation of community-led and peer-led initiatives aimed at education and support.

The HIV diagnosis market size is expected to see rapid growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to public health campaigns and awareness initiatives, focus on equity and inclusivity, routine testing in healthcare settings, community-led and peer-led approaches, and expansion of self-testing. Major trends in the forecast period include advancements in testing technologies, focus on targeted testing strategies, community-based testing and outreach, emphasis on equity and inclusivity, and policy and funding priorities.

The anticipated increase in blood donation is poised to drive the expansion of the HIV diagnosis market in the foreseeable future. Blood donation, characterized by the voluntary act of giving blood through phlebotomy, has seen a rise attributed to advancements in medical technology, heightened community engagement, and enhanced donor recruitment and retention strategies. This surge in blood donation results in a larger pool of samples available for HIV testing. Consequently, the heightened availability of blood samples facilitates more comprehensive screening for HIV antibodies or antigens, thereby improving the accuracy and reliability of HIV diagnosis. For example, NHS Blood and Transplant, a UK-based government agency, reported an increase in new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024, underscoring the pivotal role of rising blood donation in propelling the growth of the HIV diagnosis market.

Major players in the HIV diagnosis market are actively developing chip-based real-time PCR test solutions tailored for HIV, aimed at enhancing accuracy, reducing turnaround time, and improving accessibility. Chip-based real-time PCR test solutions utilize microfluidic chips or small integrated circuits to conduct real-time polymerase chain reaction (PCR) tests for HIV detection. For instance, in August 2022, Molbio Diagnostics, an India-based molecular diagnostics manufacturer, unveiled the Truenat HIV-1 test, a chip-based real-time PCR test designed for the quantitative detection and diagnosis of human immunodeficiency virus type 1 (HIV-1) in whole blood and plasma. Leveraging Taqman chemistry, this test boasts high primer sensitivity and specificity, requiring minimal sample volume and featuring an intelligent chip with lot-specific data for result quantification, along with contamination- and evaporation-resistant design elements.

In May 2022, Roche, a Switzerland-based biopharmaceutical and diagnostic company, forged a partnership with the Global Fund, aiming to bolster diagnostic infrastructure in low- and middle-income countries. This collaboration seeks to facilitate improved diagnosis and treatment of HIV and tuberculosis within the framework of Roche's Global Access Program and the Global Fund's broader initiatives targeting HIV, tuberculosis, and malaria globally. The Global Fund, an international financing and partnership organization headquartered in Switzerland, focuses on providing grants to strengthen health systems addressing HIV/AIDS.

Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.

North America was the largest region in the HIV diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the human immunodeficiency virus (HIV) diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human immunodeficiency virus (HIV) diagnosis market consists of revenues earned by entities by providing services such as HIV testing, pre-test counseling, post-test counseling, laboratory-based testing, point-of-care testing, partner notification services, and linkage to care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The human immunodeficiency virus (HIV) diagnosis market also includes sales of diagnostic kits, testing equipment such as enzyme-linked immunosorbent assay (ELISA) readers and polymerase chain reaction (PCR) machines, point-of-care testing devices, laboratory equipment such as centrifuges and microscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human immunodeficiency virus (HIV) diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human immunodeficiency virus (HIV) diagnosis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human immunodeficiency virus (HIV) diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Consumables; Instruments; Software And Services
2) By Mode: Self-Test; Lab-Based
3) By End User: Diagnostic Laboratories; Hospitals; Research Institutions
Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers; Roche Diagnostics; Becton Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18153

1. Executive Summary

2. Human Immunodeficiency Virus (HIV) Diagnosis Market Characteristics

3. Human Immunodeficiency Virus (HIV) Diagnosis Market Trends And Strategies

4. Human Immunodeficiency Virus (HIV) Diagnosis Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Size and Growth

5.1. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Human Immunodeficiency Virus (HIV) Diagnosis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Human Immunodeficiency Virus (HIV) Diagnosis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Human Immunodeficiency Virus (HIV) Diagnosis Market Segmentation

6.1. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Consumables
Instruments
Software And Services
6.2. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Self-Test
Lab-Based
6.3. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Diagnostic Laboratories
Hospitals
Research Institutions

7. Human Immunodeficiency Virus (HIV) Diagnosis Market Regional And Country Analysis

7.1. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market

8.1. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Human Immunodeficiency Virus (HIV) Diagnosis Market

9.1. China Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
9.2. China Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Human Immunodeficiency Virus (HIV) Diagnosis Market

10.1. India Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market

11.1. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
11.2. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market

12.1. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market

13.1. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market

14.1. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
14.2. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market

15.1. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
15.2. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Human Immunodeficiency Virus (HIV) Diagnosis Market

16.1. UK Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market

17.1. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Human Immunodeficiency Virus (HIV) Diagnosis Market

18.1. France Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market

19.1. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market

20.1. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market

21.1. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
21.2. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market

22.1. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Human Immunodeficiency Virus (HIV) Diagnosis Market

23.1. North America Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
23.2. North America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Human Immunodeficiency Virus (HIV) Diagnosis Market

24.1. USA Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
24.2. USA Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market

25.1. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
25.2. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Human Immunodeficiency Virus (HIV) Diagnosis Market

26.1. South America Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
26.2. South America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market

27.1. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market

28.1. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
28.2. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market

29.1. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
29.2. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Landscape And Company Profiles

30.1. Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Landscape
30.2. Human Immunodeficiency Virus (HIV) Diagnosis Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Abbott Laboratories
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Siemens Healthineers
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Roche Diagnostics
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Becton Dickinson and Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Human Immunodeficiency Virus (HIV) Diagnosis Market Other Major And Innovative Companies

31.1. Hologic Inc.
31.2. bioMerieux SA
31.3. Beckman Coulter Inc.
31.4. Bio-Rad Laboratories Inc.
31.5. QIAGEN N.V.
31.6. Bio-Techne Corporation
31.7. Alere Inc.
31.8. Cepheid Inc.
31.9. OraSure Technologies Inc.
31.10. Advanced Instruments Inc.
31.11. BBI Solutions
31.12. Chembio Diagnostic Systems Inc.
31.13. BioLytical Laboratories Inc.
31.14. Avioq Inc.
31.15. Advanced Biochemicals Ltd.

32. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Benchmarking

33. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Human Immunodeficiency Virus (HIV) Diagnosis Market

35. Human Immunodeficiency Virus (HIV) Diagnosis Market Future Outlook and Potential Analysis

35.1 Human Immunodeficiency Virus (HIV) Diagnosis Market In 2028 - Countries Offering Most New Opportunities
35.2 Human Immunodeficiency Virus (HIV) Diagnosis Market In 2028 - Segments Offering Most New Opportunities
35.3 Human Immunodeficiency Virus (HIV) Diagnosis Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer